logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12403136 B1

PDFFull Text
Date of Patent:
Sep. 02, 2025

Filed:

Jul. 17, 2020

Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

Applicant:

Jazz Pharmaceuticals Research Uk Limited, Sittingbourne, GB;

Inventors:

Alan Silcock, Cambridge, GB;

Benjamin Whalley, Cambridge, GB;

Royston Gray, Cambridge, GB;

Hannah Straker, Cambridge, GB;

Karen Tse, Cambridge, GB;

Alexander Cobb, London, GB;

Laura Bryant, Leigh-on-Sea, GB;

Assignee:

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, Sittingbourne, GB;

Attorney:

COOLEY LLP

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Heather undefined Dahlin

Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/05 (2006.01); A61K 31/055 (2006.01); A61K 31/353 (2006.01); A61K 45/06 (2006.01); A61P 25/08 (2006.01); C07C 37/16 (2006.01); C07C 39/23 (2006.01); C07C 41/06 (2006.01); C07D 215/06 (2006.01); C07D 215/14 (2006.01); C07D 215/20 (2006.01); C07D 215/48 (2006.01); C07D 311/58 (2006.01); C07D 311/64 (2006.01);
U.S. Cl.
CPC ...
A61K 31/47 (2013.01); A61K 31/05 (2013.01); A61K 31/055 (2013.01); A61K 31/353 (2013.01); A61K 45/06 (2013.01); A61P 25/08 (2018.01); C07C 37/16 (2013.01); C07C 39/23 (2013.01); C07C 41/06 (2013.01); C07D 215/06 (2013.01); C07D 215/14 (2013.01); C07D 215/20 (2013.01); C07D 215/48 (2013.01); C07D 311/58 (2013.01); C07D 311/64 (2013.01);
Abstract

The present invention relates to a group of cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof. The cannabinoid derivatives of the invention are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the cannabinoid derivatives of the invention

Find Patent Forward Citations

Loading…